Sanofi
A global biopharmaceutical company that discovers, develops, and markets medicines and vaccines.
SAN | PA
Overview
Corporate Details
- ISIN(s):
- FR0000120578 (+39 more)
- LEI:
- 549300E9PC51EN656011
- Country:
- France
- Address:
- 46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
- Sector:
- Manufacturing
Description
Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-09-25 09:00 |
Communiqué de presse : ALTUVIIIO® une fois par semaine, une nouvelle classe de …
|
French | PDF • 163.6 KB | ||
| 2023-09-25 09:00 |
Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of facto…
|
English | PDF • 179.0 KB | ||
| 2023-09-22 07:30 |
Communiqué de presse : Mise en ligne du document « Q3 2023 Memorandum for model…
|
French | PDF • 143.4 KB | ||
| 2023-09-22 07:30 |
Press Release: Availability of the Q3 2023 Memorandum for modelling purposes
|
English | PDF • 134.6 KB | ||
| 2023-09-19 08:30 |
Press Release: Sanofi supporting vulnerable communities as part of commitment t…
|
English | PDF • 238.8 KB | ||
| 2023-09-19 08:30 |
Communiqué de presse : Sanofi soutient les communautés vulnérables dans le cadr…
|
French | PDF • 231.5 KB | ||
| 2023-09-11 20:02 |
Sanofi: Information concerning the total number of voting rights and shares - A…
|
English | PDF • 145.2 KB | ||
| 2023-09-11 20:02 |
Sanofi: Informations relatives au nombre de droits de vote et d'actions AOUT 20…
|
French | PDF • 121.5 KB | ||
| 2023-09-05 12:19 |
6-K
|
English | ZIP • 27.1 KB | ||
| 2023-08-31 07:30 |
Press Release: Sanofi announces changes to its Executive Committee
|
English | PDF • 128.6 KB | ||
| 2023-08-31 07:30 |
Communiqué de presse: Sanofi annonce des changements au sein de son Comité exéc…
|
French | PDF • 300.4 KB | ||
| 2023-08-15 21:24 |
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juill…
|
French | PDF • 121.7 KB | ||
| 2023-08-15 21:24 |
Sanofi: Information concerning the total number of voting rights and shares - J…
|
English | PDF • 145.1 KB | ||
| 2023-08-10 15:50 |
6-K
|
English | ZIP • 29.9 KB | ||
| 2023-08-03 21:21 |
Communiqué de presse : Le Comité consultatif des CDC des États-Unis recommande …
|
French | PDF • 266.6 KB |
Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sanofi
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sanofi via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-02 | N/A | Other | Buy | 71,423 | N/A |
| 2024-04-26 | N/A | Other | Buy | 1,000 | 91,380.00 EUR |
| 2023-06-09 | N/A | Other | Buy | 9 | 856.04 EUR |
| 2023-05-02 | N/A | Other | Buy | 65,205 | 6,364,008.00 EUR |
| 2023-05-02 | N/A | Other | Buy | 500 | 48,835.00 EUR |
Peer Companies
